News Digest / Ticker: OXB.L

Ticker: OXB.L

03:40am, Friday, Mar 27, 2026

Oxford BioMedica Holds Steady on 2026 Revenue and EBITDA Forecasts Amid US Expansion

Oxford BioMedica reaffirms its 2026 revenue guidance of £220-240m with key US facility addition cutting capital expenditure to £50m, while projecting progress in EBITDA margins despite near-term technology transfer costs.

06:50am, Monday, Jul 28, 2025

Oxford BioMedica H1 Revenues Surge 40%, Backlog Hits £222M-Shares Set for 50% Upside